Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
24,477,028
-
Shares change
-
-297,355
-
Total reported value, excl. options
-
$364,711,030
-
Value change
-
-$4,216,374
-
Number of buys
-
32
-
Number of sells
-
37
-
Price
-
$14.90
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2018
94 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of 30 Jun 2018.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) had 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,477,028 shares of stock of the company.
Largest 10 holders included NWQ Investment Management Company, LLC, FRANKLIN RESOURCES INC, WYNNEFIELD CAPITAL INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, HEARTLAND ADVISORS INC, THOMSON HORSTMANN & BRYANT INC, and INVESTMENT COUNSELORS OF MARYLAND LLC.
This table shows the top 88 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.